Oncogenetics service and the Brazilian public health system: the experience of a reference Cancer Hospital

Oncogenetics service and the Brazilian public health system: the experience of a reference Cancer Hospital

Show other versions (1)

Abstract The identification of families at-risk for hereditary cancer is extremely important due to the prevention potential in those families. However, the number of Brazilian genetic services providing oncogenetic care is extremely low for the continental dimension of the country and its populatio...

Full description

Bibliographic Details
Main Authors:	Edenir I. Palmero, Henrique C.R. Galvão, Gabriela C. Fernandes, André E. de Paula, Junea C. Oliveira, Cristiano P. Souza, Carlos E. Andrade, Luis G.C. Romagnolo, Sahlua Volc, Maximiliano C. Neto, Cristina Sabato, Rebeca Grasel, Edmundo Mauad, Rui M. Reis, Rodrigo A.D. Michelli
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Genética 2016-01-01
Series:	Genetics and Molecular Biology
Subjects:	oncogenetics hereditary cancer public health
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572016005001103&lng=en&tlng=en

Similar Items

Oncogenetics service and the Brazilian public health system: the experience of a reference Cancer Hospital
by: Edenir I. Palmero, et al.
Published: (2016-05-01)

Eleven Years of Oncogenetic Consultations in a Swiss Center: Patient and Testing Characteristics
by: Grandjean B, et al.
Published: (2023-11-01)

Insights from 25 years of oncogenetics: one person’s perspective
by: Eitan Friedman
Published: (2023-05-01)

Oncogenetic network estimation with disjunctive Bayesian networks
by: Phillip B. Nicol, et al.
Published: (2021-06-01)

Variable selection for disease progression models: methods for oncogenetic trees and application to cancer and HIV
by: Katrin Hainke, et al.
Published: (2017-08-01)

Advancing precision oncology through systematic germline and tumor genetic analysis: The oncogenetic point of view on findings from a prospective multicenter clinical trial of 666 patients
by: Benoit Mazel, et al.
Published: (2023-09-01)

Artificial Intelligence Techniques and Pedigree Charts in Oncogenetics: Towards an Experimental Multioutput Software System for Digitization and Risk Prediction
by: Luana Conte, et al.
Published: (2024-03-01)

A Collaborative Model to Implement Flexible, Accessible and Efficient Oncogenetic Services for Hereditary Breast and Ovarian Cancer: The C-MOnGene Study
by: Julie Lapointe, et al.
Published: (2021-05-01)

Tumor BRCA testing can reveal a high tumor mutational burden related to POLE pathogenic variants
by: M.-C. Villy, et al.
Published: (2021-08-01)

Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment
by: Nerea Vega-García, et al.
Published: (2021-02-01)

Cutaneous Melanomas Arising during Childhood: An Overview of the Main Entities
by: Arnaud de la Fouchardière, et al.
Published: (2021-08-01)

Hereditary Cancer Syndrome in a Family with Double Mutation in <i>BRIP1</i> and <i>MUTYH</i> Genes
by: Giovanna D’Elia, et al.
Published: (2023-02-01)

Big Data Sharing: A Crucial Democratic Issue for Genomic Medicine
by: Benjamin Derbez
Published: (2018-11-01)

The Clinical Significance of Unknown Sequence Variants in BRCA Genes
by: Antonio Russo, et al.
Published: (2010-09-01)

MiR-3682 promotes the progression of hepatocellular carcinoma (HCC) via inactivating AMPK signaling by targeting ADRA1A
by: Wenyue Zhao, et al.
Published: (2022-01-01)

BRACAVENIR: an observational study of expectations and coping in young women with high hereditary risk of breast and ovarian cancer
by: Fabrice Kwiatkowski, et al.
Published: (2019-02-01)

Extracting Fitness Relationships and Oncogenic Patterns among Driver Genes in Cancer
by: Xindong Zhang, et al.
Published: (2017-12-01)

Using Co-segregation and Loss of Heterozygosity Analysis to Define the Pathogenicity of Unclassified Variants in Hereditary Breast Cancer Patients
by: Rebeca Silveira Grasel, et al.
Published: (2020-10-01)

The role of genetic testing in the prognosis and management of solid tumors. A literature review
by: Radoi Viorica-Elena, et al.
Published: (2023-07-01)

The history of families at-risk for hereditary breast and ovarian cancer: what are the impacts of genetic counseling and testing?
by: Natalia Campacci, et al.
Published: (2024-03-01)

Population‐based screening of Uruguayan Ashkenazi Jews for recurrent BRCA1 and BRCA2 pathogenic sequence variants
by: Cecilia Castillo, et al.
Published: (2022-06-01)

Whole-Exome Sequencing Identifies Pathogenic Germline Variants in Patients with Lynch-Like Syndrome
by: Wellington dos Santos, et al.
Published: (2022-08-01)

Cancer-related worry and risk perception in Brazilian individuals seeking genetic counseling for hereditary breast cancer
by: Edenir Inêz Palmero, et al.
Published: (2020-04-01)

Clinical and Molecular Assessment of Patients with Lynch Syndrome and Sarcomas Underpinning the Association with <i>MSH2</i> Germline Pathogenic Variants
by: Nathália de Angelis de Carvalho, et al.
Published: (2020-07-01)

How and when to refer patients for oncogenetic counseling in the era of PARP inhibitors
by: Zoé Neviere, et al.
Published: (2020-02-01)

Haplotypic characterization of BRCA1 c.5266dupC, the prevailing mutation in Brazilian hereditary breast/ovarian cancer
by: Renan Gomes, et al.

Timed hazard networks: Incorporating temporal difference for oncogenetic analysis.
by: Jian Chen
Published: (2023-01-01)

Distinct malignant behaviors of mouse myogenic tumors induced by different oncogenetic lesions.
by: Simone eHettmer, et al.
Published: (2015-02-01)

Coinheritance of hereditary spherocytosis and reversibility of cirrhosis in a young female patient with hereditary hemochromatosis
by: Höblinger A, et al.
Published: (2009-04-01)

Disorders of the erythrocyte membrane
by: Sophia Delicou, et al.
Published: (2015-12-01)

Population prevalence of hereditary breast cancer phenotypes and implementation of a genetic cancer risk assessment program in southern Brazil
by: Edenir I. Palmero, et al.
Published: (2009-01-01)

Effect of comprehensive oncogenetics training interventions for general practitioners, evaluated at multiple performance levels.
by: Elisa J F Houwink, et al.
Published: (2015-01-01)

Negotiating jurisdictional boundaries in response to new genetic possibilities in breast cancer care: The creation of an ‘oncogenetic taskscape’
by: Wright, S, et al.
Published: (2019)

YB1 associates with oncogenetic roles and poor prognosis in nasopharyngeal carcinoma
by: Yuting Zhan, et al.
Published: (2022-03-01)

Cost-Effectiveness of BRCA 1/2 Genetic Test and Preventive Strategies: Using Real-World Data From an Upper-Middle Income Country
by: Marina Lourenção, et al.
Published: (2022-07-01)

STIL Acts as an Oncogenetic Driver in a Primary Cilia-Dependent Manner in Human Cancer
by: Jingxian Li, et al.
Published: (2022-01-01)

Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL
by: Mathieu Simonin, et al.
Published: (2021-05-01)

The clinical spectrum and prevalence of hereditary ophthalmopathology child population in 12 districts of the Rostov region
by: O. L. Kireeva, et al.
Published: (2014-07-01)

To the question of the enforcement of the performance of the hereditary contract after the death of the transferor
by: Олександр Євгенович Кухарєв
Published: (2016-09-01)

Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes
by: Christie G Turin, et al.
Published: (2023-01-01)